Target Therapies for Systemic Mastocytosis: An Update

Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MCs) in extra-cutaneous organs. It could be divided into indolent SM, smoldering SM, SM with an associated hematologic (non-MC lineage) neoplasm, aggressive SM, and mast cell leukemia. SM is generally associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sciumè, Mariarita, De Magistris, Claudio, Galli, Nicole, Ferretti, Eleonora, Milesi, Giulia, De Roberto, Pasquale, Fabris, Sonia, Grifoni, Federica Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229771/
https://www.ncbi.nlm.nih.gov/pubmed/35745657
http://dx.doi.org/10.3390/ph15060738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229771/
https://www.ncbi.nlm.nih.gov/pubmed/35745657
http://dx.doi.org/10.3390/ph15060738

Ejemplares similares